Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Methyl Isocyanate → Temozolomide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Methyl Isocyanate | HCID 12228 | — |
| 반응물 | 4-amino-1H-imidazole-2-carboxamide | HCID 21983288 | — |
| 반응물 | 5-diazo-1H-imidazole-4-carboxamide | HCID 136377446 | — |
| 용매 | Dichloromethane | HCID 6344 | — |
| 생성물 | Temozolomide | HCID 5394 | — |
반응 단계
In this process, 5-amino-1H-imidazole-carboxamide (A) is converted into 5-diazo-1H-imidazole-4-carboxamide (B), which is then cyclized with methylisocyanate in dichloromethane to provide a high yield of clinical-grade Temozolomide. However, this process requires isolation of the unstable and potentially dangerous 5-diazo-1H-imidazole-4-carboxamide (B). Moreover, methylisocyanate is a difficult reagent to handle and ship, especially on the industrial scale, and indeed is better avoided in industrial manufacture. Furthermore, the cycloaddition of methylisocyanate requires a very long reaction time: Table I in J. Med. Chem. 1984, 27, 196-201, suggests 20 days.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07737284B2 |
| 출처 데이터셋 | uspto-grants-2010_06 |
| ORD ID | ord-d39ed1e4e8d04f3592ef23528a553348 |
| 출처 메모 | uspto-grants-2010_06 |